Rubius Therapeutics : Appoints Susanne Schaffert, Ph.D., to its Board of Directors - Form 8-K

Rubius Therapeutics Appoints Susanne Schaffert, Ph.D., to its Board of Directors


CAMBRIDGE, Mass., July 14, 2022 - Rubius Therapeutics, Inc. , a clinical-stage... | July 14, 2022

Related Keywords

Rhode Island ,United States ,Boston ,Massachusetts ,Cambridge ,Cambridgeshire ,United Kingdom ,Lori Murray ,Pabloj Cagnoni ,Susanne Schaffert ,Anne Prener ,Linkedin ,Twitter ,Global Novartis Oncology Leadership Team ,Nasdaq ,Novartis ,Exchange Commission ,Rubius Therapeutics Inc ,University Of Erlangen Germany ,Facebook ,Boston Globe ,Corporate Affairs ,Rubius Therapeutics Appoints Susanne Schaffert ,Red Cell Therapeutics ,Novarti Oncology Business ,Region Head ,Novartis Oncology Europe ,Accelerated Advanced Applications ,Investor Relations ,Global Franchise Head ,Novartis Germany ,Norganic Chemistry ,Providence Business ,Private Securities Litigation Reform Act ,Red Cell Therapeutic ,Annual Report ,Quarterly Report ,Chief Corporate Affairs Officer ,Rubius Therapeutics ,Nc Stock Exchange ,News ,Information ,Press Release ,Rubius ,Herapeutics ,Ppoints ,Ausanne ,O ,Its ,Board ,F ,July ,022 ,Ubius Ruby Us78116t1034 ,